期刊
BIOSENSORS & BIOELECTRONICS
卷 143, 期 -, 页码 -出版社
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2019.111561
关键词
Organic electrochemical transistor; Bioelectronics; Nanoporous membrane; Biosensor; Amyloid-beta
类别
资金
- KAUST Office of Sponsored Research (OSR) [CRF-2019-SENSORS-2719]
Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with severe memory loss and impaired cognitive skills. A common pathological change found in AD-affected brains is the accumulation of a peptide named amyloid-beta (A beta) that can form plaques. All aggregates are visible to structural scanning tools; however, these bulky and expensive instruments are accessible to trained personnel in clinical settings only, thus hampering timely diagnosis of the disease, particularly in low-resource settings. In this work, we design an organic electrochemical transistor (OECT) for in vitro detection of A beta aggregates in human serum. The OECT channel is integrated with a nanostructured isoporous membrane which has a strong affinity for All aggregates. The detection mechanism relies on the membrane capturing A beta aggregates larger than the size of its pores and thus blocking the penetration of electrolyte ions into the channel underneath. Combining the high transconductance of the OECT with the precise porosity and selectivity of the membrane, the device detects the presence of A beta aggregates in human serum samples with excellent sensitivity. This is the first-time demonstration of a biofunctionalized, nanostructured, and isoporous membrane integrated with a high-performance transistor for biosensing. This robust, low-power, non-invasive, and miniaturized sensor aids in the development of point-of-care tools for early diagnosis of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据